Overview

Antibodies are essential molecular tools in biopharma R&D, with their specificity and consistency directly impacting experimental reliability. Built on ACRO’s integrated end-to-end antibody development platform, we offer a comprehensive portfolio of high-quality antibodies, including anti-idiotypic, ADC-specific, universal tag, isotype control, and IHC antibodies. Designed for key applications such as ELISA, flow cytometry, and Western blot, our antibodies support biopharma R&D from early research through clinical translation.
Overview
  • Rigorous Full-process Evaluation

    Rigorous Full-process Evaluation

    All antibodies go through multi-dimensional assessment covering discovery, expression, purification and real-scenario application validation to ensure reliable overall performance.

  • Outstanding Comprehensive Performance

    Outstanding Comprehensive Performance

    Possess excellent target specificity and structural stability, avoiding false signals and performance attenuation during long-term biopharma testing.

  • Wide Scenario Adaptability

    Wide Scenario Adaptability

    Fully compatible with key workflows of biologic research, quality control and clinical translation, providing consistent high-quality tool support for the full drug development pipeline.

Product Categories

Our Services

  • Custom Antibody Development Service

    End-to-end custom antibody development - covering anti-idiotype, IHC, flow cytometry, and diverse antibody formats. Efficient project delivery.

    Inquire Now arrow-rightarrow-right
    Custom Antibody Development Service
  • Antibody Expression & Production Service

    Based on AI-designed antibody sequences, we provide full services from gene synthesis, high-throughput screening to antibody production and multi-dimensional functional validation.

    Inquire Now arrow-rightarrow-right
    Antibody Expression & Production Service

Why Choose ACROBiosystems

  • End-to-End In-House Platform

    Five integrated platforms cover the full antibody workflow from discovery to validation, supporting development from lab-scale studies to commercial manufacturing.

  • Comprehensive Antibody Portfolio

    A broad antibody portfolio supports ADC, cell therapy, virology and pathology research, including anti-idiotypic, anti-payload, IHC, secondary antibodies and isotype controls.

  • Biopharma R&D Solutions

    Custom antibody development and standardized reagents support target discovery, ADC QC, immunogenicity assays and biomarker analysis across biopharma R&D.

  • Full-Lifecycle Quality Control

    Rigorous QC ensures high purity, stable bioactivity and lot-to-lot consistency, with comprehensive validation data supporting research and preclinical studies.